| Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection R Escudero-Sánchez, M Ruiz-Ruigómez, J Fernández-Fradejas, ... Journal of Clinical Medicine 10 (1), 2, 2020 | 18 | 2020 |
| Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence … R Escudero-Sanchez, A Muriel García, S García Fernández, ... Journal of Antimicrobial Chemotherapy 77 (7), 1996-2002, 2022 | 7 | 2022 |
| Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir LQ Muñoz, J Fernández-Fradejas, H Martinez-Barros, MS Cuervo, ... European Journal of Hospital Pharmacy, 2023 | 1 | 2023 |
| Potentially inappropriate prescribing in older people living with HIV: A scoping review M Vélez-Díaz-Pallarés, ED Silveira, JF Fradejas, BM Llorente, ... JAIDS Journal of Acquired Immune Deficiency Syndromes, 10.1097, 2022 | 1 | 2022 |
| 5PSQ-042 Toxicity of remdesivir as treatment of non-critically ill COVID-19 patients L Quesada, J Fernández-Fradejas, HM Barros, MM Rufo, RP Recuenco, ... European Journal of Hospital Pharmacy 29 (Suppl 1), A132-A132, 2022 | 1 | 2022 |
| Deprescribing in older patients with advanced cancer referred to palliative care J Fernández-Fradejas, H Martínez-Barros, L Rexach-Cano, ... BMJ Supportive & Palliative Care, 2024 | | 2024 |
| 6ER-031 Exclusion of people living with HIV from oncohaematological clinical trials with immune checkpoint inhibitors SR Tierno, HM Barros, JF Fradejas, MV Díaz-Pallarés, AMÁ Díaz European Journal of Hospital Pharmacy 31 (Suppl 1), A238-A239, 2024 | | 2024 |
| Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV J Fernández‐Fradejas, E Delgado‐Silveira, E González‐Burgos, ... HIV medicine, 2024 | | 2024 |
| 5PSQ-132 Pharmacogenetic-guided treatment in patients with dyhydropirymidine dehydrogenase deficiency JF Fradejas, M Morín-Rodríguez, E Gemeno-López, E Delgado-Silveira, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A154-A155, 2023 | | 2023 |
| 4CPS-196 Potentially inappropiate medications and potentially prescribing omissions in older people living with HIV JF Fradejas, M Vélez-Díaz-Pallarés, E Delgado-Silveira, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A89-A89, 2023 | | 2023 |
| 5PSQ-203 Polypharmacy and potentially inappropriate medications in elderly oncohaematological patients referred to palliative care: application of the STOPPFrail criteria JF Fradejas, HM Barros, LR Cano, E Delgado-Silveira, AMÁ Díaz European Journal of Hospital Pharmacy 28 (Suppl 1), A155-A155, 2021 | | 2021 |
| 4CPS-083 Safety and tolerability of palbociclib in clinical practice in a tertiary hospital JF Fradejas, L Quesada-Muñoz, M Vélez-Díaz-Pallarés, EV Navas, ... European Journal of Hospital Pharmacy 27 (Suppl 1), A86-A86, 2020 | | 2020 |
| Introducción y objetivos EMV NAVAS, MG Cortés, MF Abad, EL Miranda, NM Jáñez, CS Serrano, ... | | |
